|
|
|
|
Western blot - Kallikrein 8 antibody - Catalytic domain (ab40954)

(enlarge)
|
|
|
|
|
Product Name
|
Kallikrein 8 antibody - Catalytic domain
|
| |
See all Kallikrein 8 antibodies (4)...
|
|
Product type
|
Primary antibodies
|
|
Description
|
Rabbit polyclonal to Kallikrein 8 - Catalytic domain
|
|
Immunogen
|
Synthetic peptide based on the catalytic domain of Human Kallikrein 8.
(Peptide available as ab43090.)
|
|
Reacts with
(species key)
|
Hu
|
|
Specificity
|
Ab 40954 reacts with human Kallikrein 8 and does not react with the other human kallikreins (hK1-7, 9-15).
We have a range of domain specific antibodies for this target. For a full list please see all Kallikrein 8 antibodies
|
|
Tested applications
(see key)
|
WB
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions WB: 1/1000 (when using colorimetric substrates such as BCIP/NBT) - 1/5000 (for chemiluminescent substrates). Predicted molecular weight: 33 kDa. A number of different splice variants and partial sequences have been reported for Kallikrein 8, the longest encodes a protein of 305 amino acids with a predicted mass of 32.97 kDa. The 260 amino acid form has a predicted mass of 28 kDa. The 164, 134 and 119 amino acid versions have a predicted mass of 17.9, 14.7 and 12.7 kDa respectively but it is unclear if these proteins are produced. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Cellular localization
|
Secreted
|
|
Research areas
|
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Serine protease >> Kallikreins Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> Kallikreins Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> Kallikreins
|
|
Relevance
|
Kallikrein 8 (hK8), also known as neuropsin, brain serine protease 1 (BSP1), tumor associated differentially expressed gene 14 (TADG14), PRSS19, HNP and ovasin, is a trypsin like serine protease. Originally described from mouse brain, KLK8 was implicated in neural plasticity and learning. Kallikrein 8 is thought to be involved in neurite outgrowth and fasciculation during nervous system development. Kallikrein 8 is induced in neurite injury, and Kallikrein 8 has been shown to be elevated in the hippocampus on Alzheimer’s patients’ brains. Animal models of autoimmune encephalomyelitis (EAE) show elevated Kallikrein 8 production. Kallikrein 8 null mice have aberrant synapses in their hippocampus, compared to wild type mice, and are predisposed to seizures. Kallikrein 8 is thought to regulate the early phase of long-term potentiation (LTP), possibly by cleaving fibronectin and other substrates. Kallikrein 8 is also found in the uterus, where it is hormonally regulated. Cervical cancer cell lines express high levels of Kallikrein 8, and it may be useful as a tumor marker. Kallikrein 8 is not limited to the brain and uterus, as many tissues and cell lines make the protein. Endogenous inhibitors include serine protease inhibitor 3 and protein C inhibitor, although Kallikrein 8 can be found complexed to a number of different protease inhibitors. A number of different splice variants and partial sequences have been reported for Kallikrein 8, the longest encodes a protein of 305 amino acids with a predicted mass of 32.97 kDa and a pI of 8.59. The 260 amino acid form has a predicted mass of 28 kDa and pI of 8.18, the 164, 134 and 119 amino acid versions 17.9, 14.7 and 12.7 kDa respectively, but it is unclear if these proteins are produced.
|
|
|
|
|
Database links
|
The links below go to external sites and will open in a new browser window
|
|
Raised in
|
Rabbit
|
|
Clonality
|
Polyclonal
|
|
Isotype
|
IgG
|
|
Purity
|
Immunogen affinity purified
|
|
Storage buffer
|
Preservative: 0.05% Sodium Azide Constituents: 50% Glycerol Material safety datasheets (MSDS) for this product: Glycerol MSDS Sodium Azide MSDS
|
|
Form
|
Liquid
|
|
Concentration
|
1.000 mg/ml
|
|
Storage instructions
|
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Kallikrein 8 antibody - Catalytic domain is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
|
See below for Kallikrein 8 antibody - Catalytic domain images, references, products related to ab40954 and other tools.
|
| |
Kallikrein 8 antibody - Catalytic domain images:
|
Western blot - Kallikrein 8 antibody - Catalytic domain (ab40954)
All lanes : Kallikrein 8 antibody - Catalytic domain (ab40954) at 1/1000 dilution
Lane 1 : Kallikrein 8 at 0.05 µg Lane 2 : Kallikrein 8 at 0.01 µg Lane 3 : Kallikrein 8 at 0.001 µg
Predicted band size : 33 kDa Observed band size : 35 kDa (why is the actual band size different from the predicted?) Additional bands at : 66 kDa (possible dimer).
|
| |
| |
|
Search PubMed (MEDLINE) for references to Kallikrein 8
|
| |
Kallikrein 8 antibody - Catalytic domain - more information
|
Customer reviews (feedback) regarding Kallikrein 8 antibody - Catalytic domain |
Customer FAQs regarding Kallikrein 8 antibody - Catalytic domain |
Protocols for Kallikrein 8 antibody - Catalytic domain |
Price and availability of products related to Kallikrein 8 antibody - Catalytic domain |
| |
Kallikrein 8 antibody - Catalytic domain - related products:
|
|
|
| |
Kallikrein 8 antibody - Catalytic domain - other tools:
|
Contact Abcam with a Technical Enquiry about Kallikrein 8 antibody - Catalytic domain |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"